ALS Drug Development Summit on May 21-23, 2024 in Boston, United States
- Event Type: Conference
- Presentation: Physical
- Website URL: http://go.evvnt.com/2215799-0?pid=10008
- Contact E-mail: [email protected]
- Location: Boston, United States
- Venue: Hyatt Regency Boston
- Date: May 21-23, 2024
- Organization: Hanson Wade
- Conference Tags: science health medicine pharmaceuticals drug development biomarkers strategy
Identify Transformative ALS Targets, Seek Translational Biomarkers and Propel More Clinical Approvals
Following monumental progress in 2023, the ALS treatment landscape is surging with novel innovation to navigate the complex, multifactorial nature of motor neuron degeneration and develop more truly transformative drugs for sporadic and familial ALS.
Capitalizing on rapid pipeline progress and emerging industry investment, the 3rd Annual ALS Drug Development Summit returns to Boston, providing a comprehensive breakdown of the latest motor neuron models, biomarker strategies, approval insights, and novel approaches to target the likes of TDP-43, STMN2, and PIKfyve. Engage in forward-thinking discussions and gain fresh perspectives on the most meaningful endpoints and trial design considerations for people living with ALS.
This May, join your industry colleagues across discovery, preclinical, clinical, regulatory, and commercial from the likes of Biogen, Amylyx, AbbVie, NeuroSense, Mitsubishi, Sanofi, Takeda, Novartis, and more.
URLs:
Tickets: https://go.evvnt.com/2215799-2?pid=10008
Brochure: https://go.evvnt.com/2215799-3?pid=10008
Time: 8:00 AM - 5:00 PM
Prices:
Industry Pricing - Conference + Workshop Day: USD 3597.00,
Industry Pricing - Conference Only: USD 2599.00,
Service Provider Pricing - Conference + Workshop Day: USD 5197.00,
Service Provider Pricing - Conference Only: USD 3699.00
Speakers: Diego Cadavid Chief Medical Officer Verge Genomics, Disha Sood Senior Scientist Sanofi , Emily Caporello Director, Small Business Program NINDS/NIH , Emma Bowden Vice President and Head of Clinical Development QurAlis Corp. , Fen Huang Director - Translational Sciences Denali Therapeutics Inc. , Fred Grossman President and Chief Medical Officer Coya Therapeutics , Howard Rutman Chief Medical Officer Xalud Therapeutics , Karen King Member Genetic ALS and FTD: End the Legacy , Lahar Mehta Vice President and Head of Global Clinical Development Amylyx Pharmaceuticals Corp. , Layne Oliff Advocate I AM ALS Laynie Dratch Genetic Counselor Penn Medicine , Machelle Manuel VP and Global Head Medical Affairs Amylyx Pharmaceuticals Corp. , Mansuo Lu Shannon Chief Scientific Officer Prevail Therapeutics , Marjan Sepassi Vice President - Medical Affairs Clene Nanomedicine , Mary Kay Turner Senior Vice President, Global Patient Advocacy and Public Affairs BrainStorm Cell Therapeutics , Neil Shneider Director The Eleanor and Lou Gehrig ALS Center, Columbia University , Neta Zach Head of Neuroscience Experimental Medicine Takeda Pharmaceutical Co. Ltd. , Paul Wicks Advocate Independent , Paul Wright Head of Motor Neuron Disease Translational Challenge LifeArc , Petra Duda Senior Executive Director - Clinical Research and Global Development Lead UCB Pharma , Philip Wong Professor Johns Hopkins University , Robert Bowser Chief Scientific Officer Barrow Neurological Institute , Sabrina Paganoni Co-Director - Neurological Clinical Research Institute Massachusetts General Hospital (MGH) and Harvard Medical School , Sakshi Sardar Senior Scientific Director, Digital and Precision Medicine Critical Path Institute , Sarah Luppino Nurse Practitioner and Healey and AMG Center for ALS Research Site Director Massachusetts General Hospital (MGH) and Harvard Medical School , Sharon Tamir Digital Healthcare Innovation, Business and Research Strategy Mitsubishi Tanabe Pharma , Shih-Ching (Joyce) Lo Associate Director Biogen , Shiran Zimri Vice President of Research and Development NeuroSense Therapeutics , Sophie Parmentier-Batteur Head of Neurodegeneration Novartis , Stacy Lindborg Co- CEO BrainStorm Cell Therapeutics , Tao Yang Director - Computational Biology Prevail Therapeutics , Wen-Hsuan Chang Head of Target Validation AcuraStem Inc. , Yuqiang Wang Chief Executive Officer Magpie Pharmaceuticals, Aarti Sharma Associate Director Regeneron Pharmaceuticals Inc , Akinori Hishiya CSO SOLA Biosciences , Angela Genge Chief Medical Officer QurAlis Corp. , Arti Patel Principle Scientist II Novartis AG , Barbara Nguyen-Vu Senior Director - Neuroscience MeiraGTx , Bijan Nejadnik Head Of Global Development, Regulatory Affairs and Quality Assurance Mitsubishi Tanabe Pharma , Christopher Ocampo Senior Medical Director Abbvie , Collin Hovinga Vice President of Rare and Orphan Diseases Critical Path Institute
Name: Hanson Wade
- August 05, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Vancouver, Canada
- November 18, 2024 International Conference on Medical and Health Sciences (ICMHS) - Singapore, Singapore
- August 08, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Baku, Azerbaijan
- May 02, 2024 International Conference on Oncology (ICO) - Honolulu, United States
- August 29, 2024 International Conference on Pediatrics (ICP) - Zanzibar, Tanzania
- July 18, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Rhodes, Greece
- June 03, 2024 International Conference on Neurology and Epidemiology (ICNE) - New York, United States
- December 23, 2024 International Conference on Ultrasonics (ICU) - Barcelona, Spain
- December 16, 2024 International Conference on Medical and Health Sciences (ICMHS) - Vientiane, Laos
- July 18, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Paris, France
- June 27, 2024 International Conference on Ultrasonics (ICU) - London, United Kingdom
- September 26, 2024 International Conference on Medical and Health Sciences (ICMHS) - San Francisco, United States
- November 04, 2024 International Conference on Oncology (ICO) - Amsterdam, Netherlands
- December 02, 2024 International Conference on Ultrasonics (ICU) - Tokyo, Japan
- May 02, 2024 International Conference on Hematology (ICH) - Honolulu, United States
- September 05, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Prague, Czechia
- July 22, 2024 International Conference on Ultrasonics (ICU) - Rome, Italy
- November 04, 2024 International Conference on Hematology (ICH) - Cape Town, South Africa
- December 02, 2024 International Conference on Oncology (ICO) - Auckland, New Zealand
- October 17, 2024 International Conference on Neurology and Epidemiology (ICNE) - Kathmandu, Nepal
- August 15, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Tokyo, Japan
- September 16, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Santiago, Chile
- October 28, 2024 International Conference on Medical and Health Sciences (ICMHS) - Lisbon, Portugal
- August 15, 2024 International Conference on Anesthesiology and Critical Care Medicine (ICACCM) - Venice, Italy
- December 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Vientiane, Laos
- June 27, 2024 International Conference on Medical and Health Sciences (ICMHS) - Nicosia, Cyprus
- June 27, 2024 International Conference on Pediatrics (ICP) - Nicosia, Cyprus
- October 28, 2024 International Conference on Pediatrics (ICP) - Lisbon, Portugal
- August 08, 2024 International Conference on Pediatrics (ICP) - Baku, Azerbaijan
- December 02, 2024 International Conference on Neurology and Epidemiology (ICNE) - Auckland, New Zealand
- July 29, 2024 International Conference on Oncology (ICO) - Vienna, Austria
- June 20, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Vienna, Austria
- May 23, 2024 International Conference on Pediatrics (ICP) - Tokyo, Japan
- December 02, 2024 International Conference on Oncology (ICO) - Sydney, Australia
- July 11, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Ottawa, Canada
- June 13, 2024 International Conference on Hematology and Oncology (ICHO) - Barcelona, Spain
- August 15, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Tokyo, Japan
- December 02, 2024 International Conference on Pediatrics (ICP) - Amsterdam, Netherlands
- September 16, 2024 International Conference on Neurology and Epidemiology (ICNE) - Paris, France
- December 30, 2024 International Conference on Medical and Health Sciences (ICMHS) - Paris, France
- August 22, 2024 International Conference on Medical and Health Sciences (ICMHS) - Budapest, Hungary
- October 17, 2024 International Conference on Medical and Health Sciences (ICMHS) - London, United Kingdom
- September 26, 2024 International Conference on Hematology (ICH) - Istanbul, Turkey
- November 07, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - Tokyo, Japan
- July 04, 2024 International Conference on Pediatrics (ICP) - Corfu, Greece
- May 16, 2024 International Conference on Pediatrics (ICP) - Sydney, Australia
- July 22, 2024 International Conference on Pediatrics (ICP) - Berlin, Germany
- September 19, 2024 International Conference on Ultrasonics (ICU) - Toronto, Canada
- August 08, 2024 International Conference on Cardiology and Cardiac Surgery (ICCCS) - New York, United States
- October 24, 2024 International Conference on Pediatrics (ICP) - Bali, Indonesia
- May 08, 2024 Boston Small Business Expo - Boston, United States
- April 29, 2024 Annual LNP Formulation and Process Development Summit - Boston, United States
- May 07, 2024 Next Generation RNA Therapeutics Summit - Boston, United States
- May 07, 2024 Ligase Targeting Drug Development Summit - Boston, United States
- May 13, 2024 PEGS Boston Summit - Boston, United States
- May 14, 2024 R AND D Procurement and Sourcing in Pharma Summit - Boston, United States
- May 21, 2024 Cytokine-Based Drug Development Summit - Boston, United States
- May 21, 2024 3D Tissue Models Summit 2024 - Boston, United States
- May 21, 2024 ADC Payload Summit - Boston, United States
- May 21, 2024 Annual Cell Engager Summit - Boston, United States